This continuing education program focuses on advancing the understanding and management of obesity and associated cardiovascular risks. Participants will review the latest literature, emphasizing the role of GLP-1 receptor agonists in reducing major adverse cardiovascular events (MACE).

This webinar will explore the complex relationship between obesity, behavior change, and cardiovascular health, equipping multidisciplinary cardiac and pulmonary rehabilitation professionals with strategies to enhance patient care.

This free webinar series, sponsored by Novo Nordisk Inc., is tailored to multidisciplinary cardiac rehabilitation professionals, and will consist of three, 60-minute live webinar presentations addressing weight management and guideline directed care in cardiovascular disease. Each live webinar will be recorded and offered on-demand in the AACVPR Learning Center. No CEUs will be offered for this series.

in this live webinar, the presenters will provide an overview of sleep apnea epidemiology, clinical presentation and cardiovascular implications. Additionally, they will also discuss how sleep disorders may impact cardiac rehabilitation outcomes.

Diabetes is a complex and prevalent condition in populations eligible for cardiopulmonary rehabilitation (CR). A significant disparity exists in the uptake and adherence of CR programs between people with and without diabetes. This webinar will update CR practitioners to factors associated with increased cardiovascular risk, patient assessment strategies, advances in diabetes-related technology, and recommendations for improving participation outcomes and optimizing glycemic control around exercise.

During this presentation, recorded as a live webinar in May 2025, Dr. Lavie will review the adverse effects of obesity and cardiovascular disease risk factors and to increase the prevalence of cardiovascular disease.

This session, recorded in April 2025, explores the evolution and impact of psychocardiology, highlighting its emergence as a critical field addressing the intersection of cardiovascular disease (CVD) and psychological distress. Participants will gain insights into key psychosocial stressors affecting CVD patients and learn how to apply screening tools and both pharmacologic and non-pharmacologic interventions to improve patient outcomes. Additionally, the session will emphasize the integration of psychosocial care into cardiac and pulmonary rehabilitation, underscoring its essential role in the early detection and management of mental health conditions to enhance overall cardiovascular and pulmonary health.

Frailty is associated with higher mortality, disability, and hospitalization in the cardiac population. It is critical to identify frail and vulnerable patients and adapt their assessment and intervention plan within the frame of primary and secondary prevention of CVDs.

This presentation will address that vast variations of the placement of Cardiac and Pulmonary Rehab Programs in an organizational structure and how these structures can negative and/or positively impact program operations and sustainability.

This webinar will address current rules and regulations as they apply to Cardiac Rehabilitation, Intensive Cardiac, SET PAD, Pulmonary Rehabilitation and Outpatient Respiratory Services programs.